Dibenzyline is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Phenoxybenzamine Hydrochloride.
Product ID | 59212-001_43b501fd-471f-41eb-b302-21fd63bc3424 |
NDC | 59212-001 |
Product Type | Human Prescription Drug |
Proprietary Name | Dibenzyline |
Generic Name | Phenoxybenzamine Hydrochloride |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1953-01-26 |
Marketing Category | NDA / NDA |
Application Number | NDA008708 |
Labeler Name | Concordia Pharmaceuticals Inc. |
Substance Name | PHENOXYBENZAMINE HYDROCHLORIDE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1953-01-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA008708 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1953-01-26 |
Ingredient | Strength |
---|---|
PHENOXYBENZAMINE HYDROCHLORIDE | 10 mg/1 |
SPL SET ID: | 8852dd44-098c-4d99-88e0-a092a8e08e11 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59212-001 | Dibenzyline | Phenoxybenzamine Hydrochloride |
0054-0349 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
49884-038 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
60219-1502 | Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride |
66993-066 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
69238-1502 | Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride |
70954-365 | Phenoxybenzamine Hydrochloride | Phenoxybenzamine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DIBENZYLINE 71586367 0548626 Live/Registered |
SMITH, KLINE & FRENCH LABORATORIES 1949-10-15 |